Integrative Research Laboratories Ab

This early-stage study tested a single dose of the drug IRL757 in 12 healthy volunteers aged 65 to 89. The goal was to see how the drug moves through the body and whether it is safe. No treatment was given for any disease, so this study does not offer a cure or symptom relief.

This early-stage study tested the safety of a new drug, IRL757, in 82 healthy adults aged 18-55. Participants received either the drug or a placebo to check for side effects and how the drug moves through the body. The study is complete and focused only on safety, not on treating…